v3.26.1
STATEMENTS OF CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]        
Sales - Note P $ 497 $ 463 $ 1,365 $ 1,347
Cost of sales - Note Q 327 331 943 957
Gross profit 170 132 422 390
Selling, general and administrative expense - Note Q 99 106 264 268
Research and development expense - Note Q 15 13 41 41
Intangibles amortization expense - Note G and Note Q 15 15 46 47
Equity and other income - Note Q 1 0 2 1
Goodwill impairment - Note G 0 706 0 706
Income (loss) on divestitures, net - Note B and Note Q 1 0 3 (165)
Operating income (loss) 43 (708) 76 (836)
Net interest and other (income) expense (8) (5) 19 34
Other net periodic benefit (income) loss - Note K (5) 1 (3) 4
Income (loss) from continuing operations before income taxes 56 (704) 60 (874)
Income tax expense (benefit) - Note J 15 15 18 (19)
Income (loss) from continuing operations 41 (719) 42 (855)
Loss from discontinued operations, net of income taxes - Note C (25) (23) (22) (22)
Net income (loss) $ 16 $ (742) $ 20 $ (877)
Basic earnings (loss) per share - Note M        
Income (loss) from continuing operations $ 0.89 $ (15.7) $ 0.91 $ (18.39)
Loss from discontinued operations (0.54) (0.51) (0.48) (0.46)
Net income (loss) 0.35 (16.21) 0.43 (18.85)
Diluted earnings (loss) per share - Note M        
Income (loss) from continuing operations [1] 0.89 (15.7) 0.91 (18.39)
Loss from discontinued operations (0.54) (0.51) (0.48) (0.46)
Net income (loss) $ 0.35 $ (16.21) $ 0.43 $ (18.85)
COMPREHENSIVE INCOME (LOSS)        
Net income (loss) $ 16 $ (742) $ 20 $ (877)
Other comprehensive income (loss), net of tax        
Unrealized translation gain (loss) 4 91 (6) 46
Unrealized (loss) gain on commodity hedges (2) (1) (2) 2
Other comprehensive income (loss) - Note N 2 90 (8) 48
Comprehensive income (loss) $ 18 $ (652) $ 12 $ (829)
[1] As a result of the loss from continuing operations attributable to Ashland during the three and nine months ended June 30, 2025, the effect of the share-based awards convertible to common stock would be antidilutive and have been excluded from the diluted EPS calculation. Convertible shares for each of the applicable periods was less than $1 million.